Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the safety of spinosad and milbemycin 5-oxime orally administered to Collies with the MDR1 gene mutation.

American journal of veterinary research - 1 Jan 2010

Sherman Jeffrey G, Paul Allan J, Firkins Lawrence D

Abstract excerpt

OBJECTIVE: To determine whether signs of avermectin (AVM)-milbemycin (MB) toxicosis would be evident in AVM-MB-sensitive Collies after treatment with an experimental formulation of spinosad alone or spinosad combined with MB 5-oxime (MBO) at doses up to 5 and 10 times the MBO maximum label dose....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anthelmintics
Share to ATP Binding Cassette Transporter, Subfamily B, Member 1
Share to Dog Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dose-Response Relationship, Drug

Share to Drug Combinations

Share to Drug Therapy, Combination

Share to Macrolides

Source

Identifiers

PMID: 20043790
DOI: 10.2460/ajvr.71.1.115

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20043790-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the safety of spinosad and milbemycin 5-oxime orally administered to Collies with the MDR1 gene mutation.PMID 20043790Read ↗

Ivermectin toxicity in an Australian Shepherd dog with the MDR1 mutation associated with ivermectin sensitivity in Collies.Semantic proximity Read ↗

[Severe adverse effects of certain veterinary drugs in collies and collie-like dogs].Semantic proximity Read ↗

Neurotoxic effects of ivermectin administration in genetically engineered mice with targeted insertion of the mutated canine ABCB1 gene.Semantic proximity Read ↗

Treatment of MDR1 mutant dogs with macrocyclic lactones.Semantic proximity Read ↗

Toxicology of Avermectins and Milbemycins (Macrocyclic Lactones) and the Role of P-Glycoprotein in Dogs and Cats.Semantic proximity Read ↗

[Adverse effects of veterinary drugs in collies and related breeds].Semantic proximity Read ↗

Loperamide-induced expression of immune and inflammatory genes in Collies associated with ivermectin sensitivity.Semantic proximity Read ↗

The Effect of the Canine ABCB1-1Δ Mutation on Sedation after Intravenous Administration of Acepromazine.Semantic proximity Read ↗

Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of collies from the northwestern United States.Semantic proximity Read ↗

The ABCB1-1Delta mutation is not responsible for subchronic neurotoxicity seen in dogs of non-collie breeds following macrocyclic lactone treatment for generalized demodicosis.Semantic proximity Read ↗

Review of prevalence, genetic aspects and adverse effects of the mdr1-1Delta mutation in dogs.Semantic proximity Read ↗

ABCB1-1 Delta (MDR1-1 Delta) genotype is associated with adverse reactions in dogs treated with milbemycin oxime for generalized demodicosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.